153 related articles for article (PubMed ID: 3366165)
1. Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects.
Langner B; Lemmer B
Eur J Clin Pharmacol; 1988; 33(6):619-24. PubMed ID: 3366165
[TBL] [Abstract][Full Text] [Related]
2. Circadian influence on effect of propranolol on exercise-induced tachycardia in healthy subjects.
Fujimura A; Kumagai Y; Sugimoto K; Nakashima H; Kajiyama H; Ebihara A; Ohashi K
Eur J Clin Pharmacol; 1990; 38(2):133-7. PubMed ID: 2338109
[TBL] [Abstract][Full Text] [Related]
3. Clinical chronopharmacology of oral sustained-release isosorbide-5-mononitrate in healthy subjects.
Lemmer B; Scheidel B; Blume H; Becker HJ
Eur J Clin Pharmacol; 1991; 40(1):71-5. PubMed ID: 2060550
[TBL] [Abstract][Full Text] [Related]
4. Lack of an interaction between propranolol and sumatriptan.
Scott AK; Walley T; Breckenridge AM; Lacey LF; Fowler PA
Br J Clin Pharmacol; 1991 Nov; 32(5):581-4. PubMed ID: 1659437
[TBL] [Abstract][Full Text] [Related]
5. Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics.
Bauer LA; Murray K; Horn JR; Opheim K; Olsen J
Eur J Clin Pharmacol; 1989; 37(3):257-60. PubMed ID: 2612540
[TBL] [Abstract][Full Text] [Related]
6. Chronopharmacokinetics and cardiovascular effects of nifedipine.
Lemmer B; Nold G; Behne S; Kaiser R
Chronobiol Int; 1991; 8(6):485-94. PubMed ID: 1799930
[TBL] [Abstract][Full Text] [Related]
7. Effects of a Finnish sauna on the pharmacokinetics and haemodynamic actions of propranolol and captopril in healthy volunteers.
Vanakoski J; Seppälä T
Eur J Clin Pharmacol; 1995; 48(2):133-7. PubMed ID: 7589027
[TBL] [Abstract][Full Text] [Related]
8. The effect of age on diurnal variation in the pharmacokinetics of propranolol in hypertensive subjects.
Shiga T; Fujimura A; Tateishi T; Ohashi K; Ebihara A
Eur J Clin Pharmacol; 1993; 44(5):489-92. PubMed ID: 8359189
[TBL] [Abstract][Full Text] [Related]
9. The effect of combined therapy on the pharmacokinetics and pharmacodynamics of verapamil and propranolol in patients with angina pectoris.
McCourty JC; Silas JH; Tucker GT; Lennard MS
Br J Clin Pharmacol; 1988 Mar; 25(3):349-57. PubMed ID: 3358897
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of long-acting propranolol 60-mg capsules: a comparative evaluation.
Marino MR; Dey M; Garg DC; Jallad NS; Dorick DM; Martinez JJ; Weidler DJ
J Clin Pharmacol; 1987 Nov; 27(11):885-91. PubMed ID: 3429696
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics and pharmacological actions of a long-acting formulation of propranolol.
Ohashi K; Ebihara A; Kondo K; Usami M
Arzneimittelforschung; 1984; 34(4):507-12. PubMed ID: 6378211
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral propranolol in normal subjects.
LeWinter MM; Crawford MH; Karliner JS; ORourke RA
Clin Pharmacol Ther; 1975 Jun; 17(6):709-12. PubMed ID: 1139862
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
Wójcicki J; Jaroszynska M; Droździk M; Pawlik A; Gawrońska-Szklarz B; Sterna R
Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol.
Garg DC; Jallad NS; Mishriki A; Chalavarya G; Kraml M; Fencik M; Weidler DJ
J Clin Pharmacol; 1987; 27(5):390-6. PubMed ID: 3693583
[TBL] [Abstract][Full Text] [Related]
15. Racemic (R,S)-propranolol versus half-dosed optically pure (S)-propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels.
Stoschitzky K; Lindner W; Egginger G; Brunner F; Obermayer-Pietsch B; Passath A; Klein W
Clin Pharmacol Ther; 1992 Apr; 51(4):445-53. PubMed ID: 1563214
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol.
Bendtsen F; Henriksen JH
J Hum Hypertens; 1989 Jun; 3 Suppl 1():139-45. PubMed ID: 2550636
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics and pharmacokinetics of single doses of ketanserin and propranolol alone and in combination in healthy volunteers.
Williams FM; Leeser JE; Rawlins MD
Br J Clin Pharmacol; 1986 Sep; 22(3):301-8. PubMed ID: 3768242
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.
Murdoch DL; Thomson GD; Thompson GG; Murray GD; Brodie MJ; McInnes GT
Br J Clin Pharmacol; 1991 Mar; 31(3):323-32. PubMed ID: 2054272
[TBL] [Abstract][Full Text] [Related]
19. Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.
Ahmad AM; Hopkins MT; Weston PJ; Fraser WD; Vora JP
Clin Endocrinol (Oxf); 2002 Apr; 56(4):431-7. PubMed ID: 11966735
[TBL] [Abstract][Full Text] [Related]
20. [Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol].
Telatyńska-Smieszek B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
Pol Arch Med Wewn; 2004 Jan; 111(1):45-51. PubMed ID: 15088420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]